DBV Technologies Details Viaskin Peanut BLA Timeline, VITESSE Data and Launch Plans at Conference
DBV Technologies (NASDAQ:DBVT) CEO Daniel Tass outlined the company's near-term regulatory plans, clinical results, and commercialization strategy for Viaskin Peanut, a skin patch being developed to...